Tag: activity

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

The phrase “Walk to Earn?” has been trending across social platforms—not because people believe walking literally generates income, but because it reflects a broader desire for financial participation that feels simple, intuitive, and effortless.

Rapid Demand for the AI Blockchain Project Leaves Just a Fraction of the Current Allocation Available Before the Next Presale Stage

New investor signal-intelligence platform reads social, forum, and news chatter across thousands of conversations — and surfaces the tickers the crowd is piling into, with the sentiment and catalysts behind them. Free to start.

SAN CARLOS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on June 18, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 140,860 shares of Iovance’s common stock to twenty-seven new, non-executive employees.